Inhibitory effects of fungal bis(naphtho-γ-pyrone) derivatives on nitric oxide production by a murine macrophage-like cell line, RAW 264.7, activated by lipopolysaccharide and interferon-γ

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 5, 2005, Pages 786-790

  Ishii, Rie ^a   Horie, Masakazu ^a   Koyama, Kiyotaka ^b   Ishikawa, Yukihiro ^c   Kitanaka, Susumu ^d  

^a SAITAMA INSTITUTE OF PUBLIC HEALTH   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d NIHON UNIVERSITY   (Japan)

Author keywords

Cephalochromin; Chaetochromin; Macrophage; Naphtho pyrone; Nitric oxide

Indexed keywords

BIS(NAPHTHO GAMMA PYRONE) DERIVATIVE; CEPHALOCHROMIN; CEPHALOCHROMIN 5 METHYL ETHER; CEPHALOCHROMIN 5,5' DIMETHYL ETHER; CHAETOCHROMIN A; CHAETOCHROMIN A 5,5' DIMETHYL ETHER; DIHYDROISOUSTILAGINOIDIN A; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANIMALS; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NITRIC OXIDE; PYRONES;

EID: 19644369018     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.786     Document Type: Article

References (22)

1. Part 12 in the series on the contents. Part 11: Wang L.-Y., Unehara T., Kitanaka S., Chem. Pharm. Bull., 53, 137-139 (2005).
2. Adams D. O., Hamilton T. A., Annu. Rev. Immunol., 2, 283-318 (1984).
3. Bonta I. L., Ben-Efraim S., J. Leukoc. Biol., 54, 613-626 (1993).
4. Farias-Eisner R., Sherman M. P., Aeberhard E., Chaudhuri G., Proc. Natl. Acad. Sci. U.S.A., 91, 9407-9411 (1994).
5. Wei X.-Q., Charles I. G., Smith A., Ure J., Feng G.-J., Huang F.-P., Xu D., Muller W., Moncada S., Liew F. Y., Nature (London), 375, 408-411 (1995).
6. MacMicking J. D., Nathan C., Horn G., Chartrain N., Fletcher D. S., Trumbauer M., Stevens K., Xie Q.-W., Sokol K., Hutchinson N., Chen H., Mudgett J. S., Cell, 81, 641-650 (1995).
7. Stuehr D. J., Marietta M. A., Proc. Natl. Acad. Sci. U.S.A., 82, 7738-7742 (1985).
8. Stuehr D. J., Marietta M. A., Cancer Res., 47, 5590-5594 (1987).
9. Nguyen T., Brunson D., Crespi C. L., Penman B. W., Wishnok J. S., Tannenbaum S. R., Proc. Natl. Acad. Sci. U.S.A., 89, 3030-3034 (1992).
10. Matsumoto M., Minato H., Mitsugi T., Katagiri K., J. Antibiot., 28, 602-604 (1975).
11. Koyama K., Ominato K., Natori S., Tashiro T., Tsuruo T., J. Pharmacoblo-Dyn., 11, 630-635 (1988).
12. Koyama K., Natori S., Itaka Y., Chem. Pharm. Bull., 35, 4049-4055 (1987).
13. Sekita S., Yoshihira K., Natori S., Udagawa S., Muroi T., Sugiyama Y., Kurata H., Umeda M., Can. J. Microbiol., 27, 766-772 (1981).
14. Koyama K., Natori S., Chem. Pharm. Bull., 35, 578-584 (1987).
15. Amano F., Noda T., FEBS Lett., 368, 425-428 (1995).
16. Ishii R., Horie M., Saito K., Arisawa M., Kitanaka S., Biochim. Biophys. Acta, 1568, 74-82 (2001).
17. Kanematsu M., Takagi K., Masuda N., Suketa Y., Biol. Pharm. Bull., 19, 949-951 (1996).
18. Ignarro L. J., Buga G. M., Wood K. S., Byrns R. E., Chaudhuri G., Proc. Natl. Acad. Sci. U.S.A., 84, 9265-9269 (1987).
19. Bradford M. M., Anal. Biochem., 72, 248-254 (1976).
20. Akaike T., Yoshida M., Miyamoto Y., Sato K., Kohno M., Sasamoto K., Miyazaki K., Ueda S., Maeda H., Biochemistry, 32, 827-832 (1993).
21. Xie Q.-W., Kashiwabara Y., Nathan C., J. Biol. Chem., 269, 4705-4708 (1994).
22. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S. I., Kimura T., Green S. J., Mak T. W., Taniguchi T., Vilček J., Science, 263, 1612-1615 (1994).